We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$49.2B
AUM Growth
+$3.24B
(+7.1%)
Cap. Flow
+$512M
Cap. Flow
% of AUM
1.04%
Top 10 Holdings %
Top 10 Hldgs %
15.87%
Holding
2,920
New
16
Increased
1,206
Reduced
1,586
Closed
85
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$23.3M |
| 2 |
Becton Dickinson
BDX
|
+$18.4M |
| 3 |
Amazon
AMZN
|
+$16.1M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$15.4M |
| 5 |
Johnson & Johnson
JNJ
|
+$14.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$48.1M |
| 2 |
LVLT
Level 3 Communications Inc
LVLT
|
+$27.7M |
| 3 |
KITE
Kite Pharma, Inc.
KITE
|
+$10.7M |
| 4 |
PRXL
Parexel International Corp
PRXL
|
+$10.3M |
| 5 |
CELG
Celgene Corp
CELG
|
+$10.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.9% |
| 2 | Technology | 16.24% |
| 3 | Healthcare | 13.01% |
| 4 | Industrials | 10.83% |
| 5 | Consumer Discretionary | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Citi Trends
CTRN
$555M
| $427K | ﹤0.01% |
16,122
-2,800
| -15% | -$65.3K |
|
2302
Global Industrial
GIC
$1.36B
| $426K | ﹤0.01% |
12,795
-2,172
| -15% | -$63.8K |
|
|
OMN
2303
DELISTED
OMNOVA Solutions Inc.
OMN
| $425K | ﹤0.01% |
42,548
-7,725
| -15% | -$82.4K |
|
2304
Abeona Therapeutics
ABEO
$356M
| $423K | ﹤0.01% |
1,067
-119
| -10% | -$49.2K |
|
|
CSBK
2305
DELISTED
Clifton Bancorp Inc.
CSBK
| $423K | ﹤0.01% |
24,725
-3,788
| -13% | -$64.3K |
|
2306
Okta
OKTA
$24.2B
| $422K | ﹤0.01% |
16,469
+3,358
| +26% | +$93.9K |
|
2307
York Water
YORW
$503M
| $422K | ﹤0.01% |
12,451
-2,186
| -15% | -$77K |
|
|
WAIR
2308
DELISTED
WESCO Aircraft Holdings Inc.
WAIR
| $422K | ﹤0.01% |
57,091
-21,531
| -27% | -$178K |
|
2309
Hovnanian Enterprises
HOV
$748M
| $421K | ﹤0.01% |
5,032
-971
| -16% | -$60.1K |
|
|
LGTY
2310
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $421K | ﹤0.01% |
36,168
-4,782
| -12% | -$57.7K |
|
2311
Arrow Financial
AROW
$659M
| $419K | ﹤0.01% |
14,725
-3,693
| -20% | -$109K |
|
|
BOLD
2312
DELISTED
Audentes Therapeutics, Inc
BOLD
| $417K | ﹤0.01% |
13,351
| – | – |
|
|
FRED
2313
DELISTED
Fred's Inc
FRED
| $416K | ﹤0.01% |
102,663
+11,956
| +13% | +$58K |
|
|
CIO
2314
DELISTED
City Office REIT
CIO
| $414K | ﹤0.01% |
31,858
-46
| -0.1% | -$603 |
|
|
WMC
2315
DELISTED
Western Asset Mortgage Capital Corporation
WMC
| $413K | ﹤0.01% |
4,148
-746
| -15% | -$75.9K |
|
|
CADE
2316
DELISTED
Cadence Bancorporation
CADE
| $412K | ﹤0.01% |
15,206
+5,549
| +57% | +$134K |
|
2317
Geospace Technologies
GEOS
$93.1M
| $411K | ﹤0.01% |
31,690
+4,687
| +17% | +$72.4K |
|
2318
Lexicon Pharmaceuticals
LXRX
$1.03B
| $411K | ﹤0.01% |
41,618
-9,173
| -18% | -$95.3K |
|
2319
The RMR Group
RMR
$327M
| $410K | ﹤0.01% |
6,916
-1,235
| -15% | -$69.5K |
|
2320
Unisys
UIS
$216M
| $408K | ﹤0.01% |
50,067
-9,091
| -15% | -$74.5K |
|
2321
NVE Corp
NVEC
$545M
| $407K | ﹤0.01% |
4,727
-903
| -16% | -$75.9K |
|
|
PRTK
2322
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $406K | ﹤0.01% |
22,665
-5,396
| -19% | -$113K |
|
|
AFI
2323
DELISTED
Armstrong Flooring, Inc.
AFI
| $405K | ﹤0.01% |
23,922
-4,156
| -15% | -$67.4K |
|
2324
Tejon Ranch
TRC
$460M
| $404K | ﹤0.01% |
19,445
-1,974
| -9% | -$40.7K |
|
2325
Freshpet
FRPT
$2.95B
| $403K | ﹤0.01% |
21,282
-4,380
| -17% | -$76.2K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2017 Portfolio in Review
As of Q4 2017, RhumbLine Advisers held 2,920 positions worth $49.2B, up 7.1% from $46B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2017: portfolio turnover was 3.5%. RhumbLine Advisers opened 16 new positions and exited 85, leaving the 2,920-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
- RhumbLine Advisers's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 187,382 shares worth $9.83M.
- RhumbLine Advisers added most to Microsoft in Q4 2017, an estimated $23.3M increase.
- RhumbLine Advisers's biggest Q4 2017 reduction was Celgene Corp, cutting an estimated $10.2M.
- RhumbLine Advisers fully exited CR Bard Inc. in Q4 2017, selling an estimated $48.1M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $49.2B portfolio in Q4 2017.
- RhumbLine Advisers opened 16 new positions and closed 85 in Q4 2017.
- RhumbLine Advisers's portfolio value rose 7.1% quarter-over-quarter to $49.2B.
Based on RhumbLine Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.